• KSCN
  • KSPAD
  • KSND
  • Contact us
  • E-Submission
ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS

Page Path

3
results for

"Central nervous system"

Filter

Article category

Keywords

Publication year

Authors

Funded articles

"Central nervous system"

Case Reports
Diffuse large B-cell lymphoma presenting as transverse myelitis
Urchiyev Zukhriddin, Jin-Ju Kang, Myoung-Ja Jeong, Sun-Young Oh
Ann Clin Neurophysiol 2022;24(2):79-83.   Published online October 31, 2022
DOI: https://doi.org/10.14253/acn.2022.24.2.79
Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin’s lymphoma. Although progressive lymphadenopathy is a typical feature, extranodal involvement may also occur, including the gastrointestinal tract, skin, bone, thyroid, and testes. Central nervous system invasion is rare, so differentiating it from diseases such as inflammatory demyelinating disorder or infection is essential. DLBCL is therefore a challenge to diagnose, especially when the first findings are neurological symptoms. We report an unusual case of DLBCL that presented as transverse myelitis.
  • 3,967 View
  • 70 Download
Primary central nervous system lymphoma (PCNSL) is a type of non-Hodgkin lymphoma confined to the central nervous system. Its diagnosis requires a stereotactic biopsy, which is an invasive procedure. Cerebrospinal fluid (CSF) analysis is less invasive and easier to perform than a stereotactic biopsy. We hereby report a PCNSL case diagnosed using CSF analysis and treated with systemic chemotherapy.
  • 2,110 View
  • 29 Download
A case of X-linked Charcot-Marie-tooth disease type 1 manifesting as recurrent alternating hemiplegia with transient cerebral white matter lesions
Minsung Kang, Sun-Jae Hwang, Jin-Hong Shin, Dae-Seong Kim
Ann Clin Neurophysiol 2021;23(2):130-133.   Published online October 29, 2021
DOI: https://doi.org/10.14253/acn.2021.23.2.130
X-linked Charcot Marie Tooth disease type 1 (CMTX1) is a clinically heterogenous X-linked hereditary neuropathy caused by mutation of the gene encoding gap junction beta 1 protein (GJB1). Typical clinical manifestations of CMTX1 are progressive weakness or sensory disturbance due to peripheral neuropathy. However, there have been some CMTX1 cases with accompanying central nervous system (CNS) manifestations. We report the case of a genetically confirmed CMTX1 patient who presented recurrent transient CNS symptoms without any symptom or sign of peripheral nervous system involvement.
  • 3,049 View
  • 64 Download
TOP